Zhengye Biotechnology Holding Limited Ordinary Shares

Zhengye Biotechnology Holding Limited Ordinary Shares

ZYBT · NASDAQ · Healthcare / Drug Manufacturers - Specialty & Generic

1.50USD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close1.50
Open1.50
Day Range1.45 – 1.59
52-Week Range0.616 – 8.01
Volume21.32K
Market Cap58.77M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.21
Dividend Yield0.00%
50-Day Avg1.60
200-Day Avg1.17

About

Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in the People's Republic of China. The company offers vaccines for swine, cattle, goats, sheep, poultry, and dogs, as well as monovalent vaccine, polyvalent vaccine, combined vaccine, and combined and polyvalent vaccine. It also develops vaccines for household animals, including rabies vaccine and Strain Flury LEP for dogs. In addition, the company exports its products to Vietnam, Pakistan, and Egypt. It serves direct-end customers, including livestock farmers and local governments; and domestic distributors and exporting distributors. The company was incorporated in 2004 and is based in Jilin, China. Zhengye Biotechnology Holding Limited operates as a subsidiary of Securingium Holding Limited.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Songlin Song
  • Employees269
  • HeadquartersNo.1 Lianmeng Road, Jilin, China, USA
  • Websitehttps://www.jlzybio.com

Leadership

  • Mr. Songlin SongCo-Chief Executive Officer · b. 1976
  • Mr. Ping WangChief Financial Officer · b. 1981
  • Mr. Zhongyao LiuChief Operating Officer · b. 1986
  • Ms. Yuhong ChengVice General Manager · b. 1977
  • Mr. Aiden HanCo-Chief Executive Officer · b. 1993

Financials

Income Statement

Currency: CNY2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue214.07M260.27M211.65M186.36M116.36M
Growth (%)-+21.58%-18.68%-11.95%-37.56%
Cost of Revenue88.67M106.75M81.80M95.06M92.49M
Gross Profit125.39M153.52M129.85M91.30M23.87M
Gross Margin58.58%58.98%61.35%48.99%20.51%
Operating Expense73.01M87.69M84.87M74.12M92.12M
Operating Income52.38M65.83M44.99M17.17M-68.25M
Operating Margin24.47%25.29%21.25%9.21%-58.66%
EBITDA70.12M85.55M72.10M42.60M-42.52M
EBITDA Margin32.76%32.87%34.06%22.86%-36.54%
Net Income38.96M46.73M31.46M11.31M-69.78M
Net Income Margin18.20%17.96%14.86%6.07%-59.97%
R&D11.37M13.42M11.90M12.79M18.01M
R&D as % of Total Revenue5.31%5.16%5.62%6.87%15.48%
Interest Expense1.05M2.84M4.42M4.04M3.40M
Interest Expense % of Total Revenue0.49%1.09%2.09%2.17%2.92%

Balance Sheet

Currency: CNY2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets445.28M519.67M499.89M493.25M436.47M
Total Liabilities126.44M162.81M160.62M140.71M129.76M
Total Equity267.47M296.50M272.85M283.96M249.85M
Cash6.28M9.75M15.07M18.60M50.33M
Total Debt30.00M64.88M89.85M-75.08M
Net Debt23.72M55.13M74.78M67.83M24.75M

Cash Flow

Currency: CNY2021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow31.81M17.34M48.18M41.05M13.33M
Investing Cash Flow-26.27M-27.33M-11.77M--12.63M
Financing Cash Flow-3.05M13.46M-18.98M-22.13M32.31M
Capital Expenditure26.40M27.33M11.60M27.77M12.63M
Free Cash Flow5.41M-9.99M36.58M13.27M703.00K
Dividends Paid11.05M21.43M39.45M16.02M16.02M
FCF to OCF17.01%-57.65%75.93%32.34%5.27%
Dividend Paid to FCF204.25%-214.40%107.84%120.72%2279.23%

Earnings

Report DateNov 15, 2024Jul 3, 2025Dec 12, 2025
EPS Estimate0.000.000.00
EPS Actual0.200.05-0.46
Surprise---
Timing---

Key Statistics & Ratios

Market Cap58.77M
Enterprise Value68.39M
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.51
Price / Book1.74
EPS-0.21
Book Value0.7818
Revenue (TTM)116.36M
Gross Profit (TTM)23.87M
EBITDA-44.62M
Profit Margin-59.97%
Operating Margin-77.04%
Return on Equity-25.17%
Return on Assets-9.48%
Shares Outstanding47.39M
Shares Float6.26M
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Ownership Breakdown

Institutions
0.91%
Insiders
16.16%
Retail / Other
82.93%

Top Institutional Holders

  • XTX Topco Ltd
    44.15K0.09%
  • Geode Capital Management, LLC
    29.07K0.06%
  • Winton Capital Group Ltd
    12.73K0.03%
  • UBS Group AG
    8.04K0.02%
  • Tower Research Capital LLC
    4.91K0.01%
  • Royal Bank of Canada
    1.23K0.00%
  • Morgan Stanley - Brokerage Accounts
    2610.00%
  • Caitong International Asset Management Co., Limited.
    10.00%
  • Amvescap Plc.
    00.00%
  • JPMorgan Chase & Co
    00.00%
  • Citadel Advisors Llc
    00.00%

Top Fund Holders

  • Fidelity Nasdaq Composite Index
    29.07K0.06%